P. Atluri, K. J. Morine, G. P. Liao, C. M. Panlilio, M. F. Berry et al., Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression, Cell Mol Biol Lett, vol.12, pp.127-138, 2007.

J. Boucher, B. Masri, D. Daviaud, S. Gesta, C. Guigne et al., Apelin, a newly identified adipokine upregulated by insulin and obesity, Endocrinology, vol.146, pp.1764-1771, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-00480981

C. Carpéné, C. Dray, C. Attané, P. Valet, M. P. Portillo et al., Castan-Laurell I. Expanding role for the apelin/APJ system in physiopathology, J Physiol Biochem, vol.63, pp.359-373, 2007.

I. Castan-laurell, M. Vítkova, D. Daviaud, C. Dray, M. Kováciková et al., Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ, Eur J Endocrinol, vol.158, pp.905-910, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00277309

V. Catalán, J. Gómez-ambrosi, A. Rodríguez, J. Salvador, and G. Frühbeck, Adipokines in the treatment of diabetes mellitus and obesity, Expert Opin Pharmacother, vol.10, pp.239-254, 2009.

B. Chandrasekaran, O. Dar, and T. Mcdonagh, The role of apelin in cardiovascular function and heart failure, Eur J Heart Fail, vol.10, pp.725-732, 2008.

C. Debard, M. Laville, V. Berbe, E. Loizon, C. Guillet et al., Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients, Diabetologia, vol.47, pp.917-925, 2004.

C. Dray, C. Knauf, D. Daviaud, A. Waget, J. Boucher et al., Apelin stimulates glucose utilization in normal and obese insulinresistant mice, Cell Metab, vol.8, pp.437-445, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00408948

P. H. Ducluzeau, N. Perretti, M. Laville, F. Andreelli, N. Vega et al., Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes, Diabetes, vol.50, pp.1134-1142, 2001.

G. Erdem, T. Dogru, I. Tasci, A. Sonmez, and S. Tapan, Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus, Exp Clin Endocrinol Diabetes, vol.116, pp.289-292, 2008.

M. V. Heinonen, A. K. Purhonen, P. Miettinen, M. Paakkonen, E. Pirinen et al., Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding, Regul Pept, vol.130, pp.7-13, 2005.

M. V. Heinonen, D. E. Laaksonen, T. Karhu, L. Karhunen, T. Laitinen et al., Effect of dietinduced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome, Nutr Metab Cardiovasc Dis, vol.19, pp.626-633, 2009.

Y. Iwanaga, Y. Kihara, H. Takenaka, and T. Kita, Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system, J Mol Cell Cardiol, vol.41, pp.798-806, 2006.

N. P. Kadoglou, H. Tsanikidis, A. Kapelouzou, I. Vrabas, I. Vitta et al., Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus, Metabolism, vol.59, pp.373-379, 2009.

F. Kim, M. Pham, E. Maloney, N. O. Rizzo, G. J. Morton et al., Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance, Arterioscler Thromb Vasc Biol, vol.28, 1982.

M. Laville, D. Auboeuf, Y. Khalfallah, N. Vega, J. P. Riou et al., Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, Glut 4, and lipoprotein lipase mRNA levels in human muscle, J Clin Invest, vol.98, pp.43-49, 1996.

L. Li, G. Yang, Q. Li, Y. Tang, M. Yang et al., Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects, Exp Clin Endocrinol Diabetes, vol.114, pp.544-548, 2006.

F. Ren, N. Zhang, J. Sun, and J. Yang, Low plasma apelin in newly diagnosed type 2 diabetes in Chinese people, Diabetes Care, vol.32, p.150, 2009.

F. Samad, M. Pandey, P. A. Bell, and D. J. Loskutoff, Insulin continues to induce plasminogen activator inhibitor 1 gene expression in insulin-resistant mice and adipocytes, Mol Med, vol.6, pp.680-692, 2000.

P. Sartipy and D. J. Loskutoff, Expression profiling identifies genes that continue to respond to insulin in adipocytes made insulin-resistant by treatment with tumor necrosis factor-alpha, J Biol Chem, vol.278, pp.52298-52306, 2003.

F. Soriguer, L. Garrido-sanchez, S. Garcia-serrano, J. M. Garcia-almeida, J. Garcia-arnes et al., Apelin levels are increased in morbidly obese subjects with Type 2 Diabetes Mellitus, Obes Surg, vol.19, pp.1574-1580, 2009.

K. Tatemoto, M. Hosoya, H. Fujii, R. Y. Kakegawa, T. Zou et al., Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor, Biochem Biophys Res Commun, vol.251, pp.471-476, 1998.

P. Yue, H. Jin, M. Aillaud-manzanera, A. C. Deng, J. Azuma et al., Apelin is necessary for the maintenance of insulin sensitivity, Am J Physiol Endocrinol Metab, vol.298, pp.59-67, 2010.

J. C. Zhong, X. Y. Yu, Y. Huang, L. M. Yung, C. W. Lau et al., Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice, Cardiovasc Res, vol.74, pp.388-395, 2007.